FAS Wealth Partners’s AbbVie ABBV Stock Holding History

FAS Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.15M	Buy	27,726 +1,375	+5%	+$255K	0.38%	56
2025 Q1	$5.52M	Buy	26,351 +1,064	+4%	+$223K	0.45%	51
2024 Q4	$4.49M	Buy	25,287 +499	+2%	+$88.7K	0.38%	63
2024 Q3	$4.9M	Buy	24,788 +808	+3%	+$160K	0.39%	60
2024 Q2	$4.11M	Buy	23,980 +945	+4%	+$162K	0.36%	63
2024 Q1	$4.19M	Buy	23,035 +582	+3%	+$106K	0.37%	62
2023 Q4	$3.48M	Buy	22,453 +625	+3%	+$96.9K	0.33%	66
2023 Q3	$3.25M	Buy	21,828 +555	+3%	+$82.7K	0.35%	62
2023 Q2	$2.87M	Buy	21,273 +1,015	+5%	+$137K	0.36%	67
2023 Q1	$3.23M	Sell	20,258 -1,988	-9%	-$317K	0.35%	57
2022 Q4	$3.6M	Buy	22,246 +1,886	+9%	+$305K	0.41%	56
2022 Q3	$2.73M	Buy	20,360 +2,792	+16%	+$375K	0.3%	55
2022 Q2	$2.69M	Buy	17,568 +2,422	+16%	+$371K	0.28%	59
2022 Q1	$2.46M	Buy	15,146 +1,638	+12%	+$266K	0.23%	67
2021 Q4	$1.83M	Buy	13,508 +2,085	+18%	+$282K	0.17%	86
2021 Q3	$1.23M	Buy	11,423 +425	+4%	+$45.8K	0.12%	111
2021 Q2	$1.24M	Buy	10,998 +1,174	+12%	+$132K	0.12%	111
2021 Q1	$1.06M	Buy	9,824 +1,117	+13%	+$121K	0.11%	115
2020 Q4	$933K	Buy	8,707 +1,200	+16%	+$129K	0.11%	120
2020 Q3	$658K	Buy	7,507 +443	+6%	+$38.8K	0.09%	139
2020 Q2	$694K	Buy	7,064 +1,098	+18%	+$108K	0.1%	129
2020 Q1	$455K	Buy	5,966 +2,995	+101%	+$228K	0.08%	138
2019 Q4	$263K	Buy	+2,971	New	+$263K	0.04%	174
2019 Q2	–	Sell	-2,844	Closed	-$229K	–	191
2019 Q1	$229K	Sell	2,844 -138	-5%	-$11.1K	0.04%	178
2018 Q4	$275K	Sell	2,982 -151	-5%	-$13.9K	0.06%	164
2018 Q3	$296K	Buy	3,133 +8	+0.3%	+$756	0.07%	153
2018 Q2	$290K	Buy	3,125 +7	+0.2%	+$650	0.08%	148
2018 Q1	$295K	Sell	3,118 -186	-6%	-$17.6K	0.09%	142
2017 Q4	$319K	Sell	3,304 -87	-3%	-$8.4K	0.08%	141
2017 Q3	$301K	Buy	3,391 +60	+2%	+$5.33K	0.08%	138
2017 Q2	$242K	Buy	+3,331	New	+$242K	0.07%	147